ASND Research and Charts

ASND - Ascendis Pharma A/S ADR (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10)

Last 224.19	Change ⇑ +2.16 (+0.97%)	Volume 967,204
	Open 221.54	High 224.83	Low 213.38

8EMA (Daily) 222.72	40EMA (Daily) 217.34	50EMA (Daily) 215.70	STO (Daily) 43.131	MACD Hist (Daily) -1.027
8EMA (Weekly) 218.985	40EMA (Weekly) 196.54	50EMA (Weekly) 190.60	STO (Weekly) 67.844	MACD Hist (Weekly) 0.694


Company Profile
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.